COMMUNIQUÉS West-GlobeNewswire

Premier Biomedical Appoints Carl Eller, NFL Retired Players Association President, as Marketing & Planning Vice-President
16/11/2017
El Paso, Texas, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTCQB: " BIEI ") announced the appointment of retired NFL Pro Football Hall of Famer, Carl Eller, to the post of Marketing and Planning Vice- [...]
Rafael Pharmaceuticals, in Collaboration with Atlantic Health System, Announces Initiation of a Phase I Study of CPI-613 in Combination with Gemcitabine and Nab-Paclitaxel for Patients with Locally Advanced or Metastatic Pancreatic Cancer
16/11/2017
Newark, NJ, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a clinical stage company and leader in the field of cancer metabolism-based therapeutics, announced today, the initiation of a Phase I clinical [...]
Zomedica Pharmaceuticals Corp. Expects Trading of its Common Shares on the NYSE American to Commence on November 21, 2017
16/11/2017
ANN ARBOR, Mich., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V: ZOM ) (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today [...]
MRI Interventions’ ClearPoint® NeuroNavigation System Achieves 2000th Procedure Milestone
16/11/2017
IRVINE, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced the 2000 th procedure completed with the ClearPoint NeuroNavigation System. The procedure was done by Dr. William [...]
IDVV announces OTC Markets Tier Upgrade as Part of Planned Company Restructure
16/11/2017
TEMECULA, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) -- International Endeavors Corporation (OTC:IDVV) ("IEC") today announced it has received Pink Current Status from OTC Markets as part of the company’s corporate [...]
OrthoPediatrics Corp. to Participate in the 29th Annual Piper Jaffray Healthcare Conference
16/11/2017
WARSAW, Ind., Nov. 16, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that Mark [...]
AxoGen, Inc. Announces Pricing of Public Offering of Common Stock
16/11/2017
ALACHUA, Fla., Nov. 16, 2017 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve damage, announced today that it [...]
Onconova Therapeutics Announces Data on Improved Formulation of Rigosertib and Next-Generation CDK4/6 Inhibitor at 2017 American Association of Pharmaceutical Scientists Annual Meeting
16/11/2017
Novel formulation of rigosertib with enhanced bioavailability and stability Liver microsomal stability of ON 123300, a first-in-class dual inhibitor of CDK4/6 + ARK5 Formulation approaches to augment bioavailability of [...]
Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors
16/11/2017
MORRISTOWN, N.J., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced the election of two new directors to [...]
Ultragenyx Announces Completion of Patient Dosing in First Cohort of Phase 1/2 Clinical Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency
16/11/2017
NOVATO, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]
ARCA Biopharma Announces Issuance of European Patent for Treating Cardiovascular Diseases and Conditions With a New Chemical Entity Utilizing Genetic Targeting
16/11/2017
WESTMINSTER, Colo., Nov. 16, 2017 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO ), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for [...]
Cytori Reports Bioequivalence Trial Results in Ovarian Cancer at AAPS
16/11/2017
Pharmacokinetic Bioequivalence Shown for Cytori’s ATI-0918 Liposomal Formulation of Doxorubicin Hydrochloride, Results Presented at the 2017 American Association of Pharmaceutical Scientists Annual Meeting SAN DIEGO, [...]
Prothena Highlights Breadth of Novel Pipeline at R&D Day
16/11/2017
Clinical development programs advancing toward key milestones Dr. Morie Gertz of Mayo Clinic discusses clinical aspects of AL amyloidosis and the role of cardiac biomarker NT-proBNP Novel discovery pipeline in [...]
Innovation Pharmaceuticals Offers Perspectives on Brilacidin as a Potential Preventative Treatment for Oral Mucositis in Head and Neck Cancer Patients
16/11/2017
BEVERLY, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals Inc. (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to provide additional perspectives on the planned [...]
Interpace Diagnostics Announces New York State Approval of New Product
16/11/2017
PARSIPPANY, N.J., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Corp. (NASDAQ: IDXG ), a fully integrated commercial company that provides clinically useful molecular diagnostic tests and pathology services [...]
Sonoma Pharmaceuticals Announces FDA Approval of Expanded Indication for Alevicyn™ to Add Antimicrobial Language
16/11/2017
PETALUMA, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, warrants SNOAW), a specialty pharmaceutical company that develops and markets unique and effective solutions for the [...]
KemPharm Completes Successful End-of-Phase 2 Meeting on KP415 with FDA
16/11/2017
All Clinical and Non-Clinical Programs Remain on Track for ADHD Prodrug Candidate, Pivotal Efficacy Trial to Study Duration of Therapy to Initiate Prior to Year-End CORALVILLE, Iowa, Nov. 16, 2017 (GLOBE NEWSWIRE) -- [...]
Stemline Therapeutics Announces Oral Presentation of SL-701 Phase 2 Data in Second-Line Glioblastoma at the 22nd Annual Meeting of the Society of Neuro-Oncology (SNO)
16/11/2017
NEW YORK, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today that data [...]
Arcturus Therapeutics Announces Completion of Merger with Alcobra Ltd. and Commences Trading on the Nasdaq Global Market
16/11/2017
Combined Company Commences Trading on the Nasdaq Global Market on November 16, 2017 under the Ticker Symbol “ARCT” Approximately $50.1 Million in Net Cash Following Closing of the Merger Ten (10) Pipeline Programs, Six [...]

Pages